The research report titled “Global Oncology Ablation Market Outlook: 2015-2020” analyzes the major drivers, restraints, opportunities, and challenges that have a long and short-term impact on the growth of oncology ablation market across the globe. This latest release from Meticulous Research® states that, the global oncology ablation market would reach $820.9 million by 2020 with a CAGR of 7.7% over the period of 2015 to 2020.
Oncology Ablation market is segmented by cancer type, technology, and geography. The technologies analyzed in this report are Radiofrequency Ablation, Microwave Ablation, Cryoablation, Ethanol Ablation, Irreversible Electroporesis (IRE), Light (Laser Ablation), and Ultrasound. Radiofrequency ablation technology commands the largest share in the oncology ablation in 2014; whereas, microwave ablation is expected to grow at a highest CAGR during 2015 to 2020. The ablation procedures for various types of cancer such as liver cancer, prostate cancer, breast cancer, lung cancer, kidney cancer, and colorectal cancer are analyzed in the report.
Increasing ageing population across the globe, technological advancements, rising adoption of these technologies, increasing demand for minimally invasive procedures, and rising risk factors including lifestyle disorders are the major factors which are driving global oncology ablation market. However, high cost of the treatment and various pharmaceutical advancements restrains the market to a certain extent.
North America is the biggest market for oncology ablation as it has highest number of cancer diagnosed peoples. The growing aging population and the increased lifestyle disorders help to drive the European oncology ablation market. On the other hand, Asia Pacific region significant opportunities for oncology ablation market mainly due to an increasing awareness of the technologically advanced products and healthcare reforms in his region. Moreover, an improved government approach towards the healthcare facilities further propels the market in this region.
The report elucidates on many various important aspects of the global oncology ablation market that facilitate the understanding of this market at a granular level. The prominent players in the oncology ablation market are AngioDynamics (U.S.), Covidien (Ireland), Boston Scientific (U.S.), BSD Medical (U.S.), Galil Medical (U.S.),, Misonix (U.S), Varian Medical Systems (U.S), Elekta AB (Sweden), Accuray .(U.S), HealthTronics (U.S.), Celon AG (Germany), NeuWave Medical (U.S.), SonaCare Medical (U.S), RF Medical Co. (Korea), STARMed Co. (Korea), and APRO KOREA (Korea) with detailed analysis of their product portfolio, financials, and recent developments.
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia¬-Pacific, and Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123
Dental Practice Management Software Market Worth $ 3.11 Billion by 2029Read More